(R)-2-(2-(pyrrolidin-3-yl)ethyl)-1,8-naphthyridine dihydrochloride, 98%, 250mg

6-Oxononanoic acid, 97.0%, 1g

ethyl 3-(dibutylamino)propanoate, 95.0%, 2g

2-(tert-Butyl)-3-(4-butylphenyl)quinazolin-4(3H)-one, 95.0%, 10g

2,4-Difluoro-1,1'-biphenyl, 95.0%, 5g

S-(7-Oxo-7-((4-phenylthiazol-2-yl)amino)heptyl) 2-methylpropanethioate, 95.0%, 25mg

3-Propyltoluene>99.0%(GC)5mL

L-Glutathione (reduced form), 98.0%, 250g

(5-Bromo-3-pyridyl)methanamine dihydrochloride, 97%, 10g

methyl 2-imino-3-(2-methoxy-2-oxoethyl)-2,3-dihydrobenzo[d]thiazole-6-carboxylate hydrobromide, 95.0%, 500mg

2-(2-Chloro-phenyl)-4,5-diphenyl-1H-imidazole, 97.0%, 25g

(S)-1-[(4-Methoxyphenyl)methyl]pyrrolidin-3-amine dihydrochloride, 1g

trans,trans-4-(3,4-Difluorophenyl)-4'-propylbicyclohexyl>98.0%(GC)5g